Security Highlights 06/16/2014
Share This:9:29 AM ET, 06/16/2014 – Street Insider bluebird bio, Inc. (Nasdaq: BLUE) 63.3% HIGHER; released initial positive clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy. Covidien … Continue reading
